期刊文献+

Effects of Composite Xinyi Aerosol (复方辛夷雾化剂) on Asthma Related Cytokines in Serum and Sputum of Patients with Bronchial Asthma 被引量:1

Effects of Composite Xinyi Aerosol (复方辛夷雾化剂) on Asthma Related Cytokines in Serum and Sputum of Patients with Bronchial Asthma
原文传递
导出
摘要 Objective: To observe the therapeutic effect of composite Xinyi ae rosol (复方辛夷雾化剂, XYA) in treating asthma and its influence on asthma relat ed cytokines in serum and sputum of patients with mild or moderate bronchial ast hma.Methods: Sixty patients were divided randomly into the treated gr oup and the control group, 30 in each group. They were treated with XYA and Salb utamol aerosol (SA) respectively by spray inhalation once a day for seven days a s one therapeutic course to observe the antiasthmatic effect of the treatment. Changes of lung function and the levels of tumor necrosis factor α (TNF-α) , interleukine-2 receptor (IL-2R) and interleukine-8 (IL-8) in serum and sputum were observed before and after treatment using enzyme linked immunos orbent assay (ELISA). Levels of TNF-α, IL-2R andIL-8 in the sputum of part of the patients in the treatment group were also observed.Results: In the treated group, 6 patients had the asthma clinica lly controlled after treatment, 12 were markedly alleviated, 9 alleviated and 3 remained unchanged, while in the control group, the respective numbers were 4, 6 , 15 and 5. The controlled-markedly effective rate of XYA was 60.0%, which wa s significantly better than that of SA (33.3%, P <0.05). The one second forc ed expiratory volume percent (FEV1%) and peek expiratory flow rate (PEFR) improv ed significantly and the levels of TNF-α, IL-2R and IL-8 in serum decr eased noticeably in both groups after treatment ( P <0.05 or P <0.01), but the improvement in the treated group was more significant as compared with tho se in the control group ( P <0.05). The levels of TNF-α, IL-2R and IL -8 in sputum considerably lowered also after XYA treatment ( P <0.01).Conclusion: XYA could regulate the related cytokines in patient s with mild or moderate bronchial asthma, and reduce the releasing of inflammato ry factors, which is consistent with the improvement of lung functions, so as to ease the airway inflammation chiefly exhibited as cell infiltration in bron chi. Objective: To observe the therapeutic effect of composite Xinyi ae rosol (复方辛夷雾化剂, XYA) in treating asthma and its influence on asthma relat ed cytokines in serum and sputum of patients with mild or moderate bronchial ast hma.Methods: Sixty patients were divided randomly into the treated gr oup and the control group, 30 in each group. They were treated with XYA and Salb utamol aerosol (SA) respectively by spray inhalation once a day for seven days a s one therapeutic course to observe the antiasthmatic effect of the treatment. Changes of lung function and the levels of tumor necrosis factor α (TNF-α) , interleukine-2 receptor (IL-2R) and interleukine-8 (IL-8) in serum and sputum were observed before and after treatment using enzyme linked immunos orbent assay (ELISA). Levels of TNF-α, IL-2R andIL-8 in the sputum of part of the patients in the treatment group were also observed.Results: In the treated group, 6 patients had the asthma clinica lly controlled after treatment, 12 were markedly alleviated, 9 alleviated and 3 remained unchanged, while in the control group, the respective numbers were 4, 6 , 15 and 5. The controlled-markedly effective rate of XYA was 60.0%, which wa s significantly better than that of SA (33.3%, P <0.05). The one second forc ed expiratory volume percent (FEV1%) and peek expiratory flow rate (PEFR) improv ed significantly and the levels of TNF-α, IL-2R and IL-8 in serum decr eased noticeably in both groups after treatment ( P <0.05 or P <0.01), but the improvement in the treated group was more significant as compared with tho se in the control group ( P <0.05). The levels of TNF-α, IL-2R and IL -8 in sputum considerably lowered also after XYA treatment ( P <0.01).Conclusion: XYA could regulate the related cytokines in patient s with mild or moderate bronchial asthma, and reduce the releasing of inflammato ry factors, which is consistent with the improvement of lung functions, so as to ease the airway inflammation chiefly exhibited as cell infiltration in bron chi.
出处 《Chinese Journal of Integrative Medicine》 SCIE CAS 2002年第4期275-278,共4页 中国结合医学杂志(英文版)
基金 AbasicapplicationitemofSciencesandTechnologyDepart mentofJiangsuProvince(BJ990 74)
关键词 ASTHMA tumor necrosis factor α interle ukin-2 receptor INTERLEUKIN-8 composite Xinyi aerosol asthma, tumor necrosis factor α, interle ukin-2 receptor, interleukin-8, composite Xinyi aerosol
  • 相关文献

参考文献1

二级参考文献2

  • 1匿名著者,中华结核和呼吸杂志,1993年,16卷,增刊,5页
  • 2刘树范,临床细胞学,1990年,63页

共引文献15

同被引文献6

  • 1Lacy P, Moqbel R. Immune effector functions of eosinophils in allergic airway inflammation [ J ]. Curr Opin Allergy Clin Immunol. 2001 Feb: 1 ( 1 ): 79-84.
  • 2Clark K, Simson L, Newcombe N, Koskinen AM, Mattes J, et al. Eosinophil degranulation in the allergic lung of mice primarily occurs in the airway lumen[ J ]. J Leukoc Biol. 2004,75(6): 1001-1009.
  • 3Shen HH, Ochkur SI, McGarry MP, et al. A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse [ J]. J Immunol.2003,170(6): 3296-3305.
  • 4徐叔云 卞如濂 陈修主编.药理实验方法学[M].北京:人民卫生出版社,1990.1178.
  • 5范欣生,周志祥,姜静,余晶华,周建英,李伟东,狄留庆,高想.中药吸入治疗中轻度支气管哮喘的临床疗效及对血、痰中IL-8水平的影响[J].中国医药学报,2001,16(2):38-41. 被引量:3
  • 6狄留庆,范欣生,赵晓莉.复方辛夷口服液的制备工艺研究[J].南京中医药大学学报,2003,19(4):222-224. 被引量:5

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部